Due to progress in retinal imaging over recent years, the relevance of the multifocal electroretinogram (mfERG) has diminished (1-4). Nevertheless, it remains an important tool in research and clinical practice as it is the only established method to objectively measure macular function (5-10). While the basic technology has not changed significantly since its invention, older devices rarely offer the possibility
ORIGINAL RESEARCH ARTICLE
to calculate group averages or to compare 2 or more examinations of the same or different patients. This complicates the interpretation of the data especially in scientific settings. Manual analysis of the data is time-consuming and prone to create errors. To amend this, a software solution for the illustration and analysis of mfERG data was developed using the open source programming language R (11).
Methods
The mfERG were recorded using a RETIport 21 system (version 7/03, Roland Consult) using a 61-hexagon stimulus and according to the standard of the International Society for Clinical Electrophysiology of Vision (12) . The exact stimulation and recording settings have been published elsewhere (13) . Recorded data were exported from the device as one .csv file for each subject and eye (see supplementary material available online at www.eur-j-ophthalmol.com).
Six scripts were developed using the open-source programming language R (11) . These scripts are available as supplemental information.
Facilitating the analysis of the multifocal electroretinogram using the free software environment R
Introduction
The first 5 scripts are only working with .csv files that were exported from a RETIport21 system. Differently structured .csv files are not recognized by these scripts. Script 6 is working only with manually compiled .csv files (see below) but is therefore independent from the recording device (see supplementary material available online at www.eur-jophthalmol.com).
Before running the scripts, all exported .csv files (scripts 1 to 5) or the manually compiled .csv files (script 6) to be analyzed and illustrated have to be copied into one source directory. In case of a comparison between groups, the .csv files of the second group are placed into a second source directory. Scripts 1 to 5 additionally require the name of an output directory where the generated plots and .csv summary files are stored. Script 6 does not generate files but only displays the plots directly in R (see supplementary material available online at www.eur-j-ophthalmol.com).
Each script serves a certain purpose and consists of different functions. Some of these functions build upon each other: one function combines the data of different patients and renders a list that the next function uses to visualize the data. Other functions are independent.
In the .csv source files exported by the RETIport system, the raw data of the mfERG recordings are stored as well as the peak characteristics (N1 and P1 amplitude, response density, and implicit time) as detected by the recording device. Only one script (script 2) accesses the raw data to calculate the average waveforms of one group. All other scripts use the peak characteristics as calculated by the RETIport system. No peak detection algorithm was implemented in our software.
To illustrate the use of the R scripts, we analyzed and compared 2 patient groups that have been described in detail (6): group 1: 11 left eyes of 11 female patients with unequivocal chloroquine maculopathy; group 2: 7 left eyes of 7 healthy female subjects. Chloroquine maculopathy was chosen for the exemplary application because of the demonstrative findings in these patients. Long-term chloroquine intake may lead to toxic maculopathy, which is characterized by (peri-)central scotoma in the automated threshold perimetry, reduced visual acuity, alterations of the outer retinal layers in optical coherence tomography, and bull´s eye maculopathy on ophthalmoscopy and fundus autofluorescence imaging (14) . The mfERG typically shows (peri-)central reductions of N1 and P1 response densities (15) .
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
As this article contains only retrospective data that were collected in clinical routine, no informed consent was obtained from the individuals.
Script 1: Summarizing the data and boxplot comparison
For each of 2 patient groups, the entire data (response densities and implicit times of N1 and P1 of every element) are compiled in one list and in one .csv file. Another .csv file contains the mean values of each element of the entire group.
On the basis of these lists, 4 plots (N1 and P1 implicit times and response densities) of each of 12 boxplots are generated, which show the comparison between both groups (Fig. 1 ). For these boxplots, the individual parameters are averaged and not the individual kernels. The characteristics of the sum response and of ring 1 to ring 5 are displayed. Moreover, the sum response and all eccentricities are compared with the ttest between both groups. Multiple testing is corrected with the Bonferroni-method. The p values are displayed on top of each of the 4 plots. p Values less than 0.05 are highlighted by bold, italic letters and asterisks.
Script 2: Average waveforms
This script calculates the average waveforms for the sum response of each group and for each ring eccentricity (ring 1 to ring 5). In a figure of 6 plots, the mean values ±2*standard deviation are displayed for each group (Fig. 2) . Furthermore, 2 .csv files are generated for each group: 1 contains the waveform data of the single examinations (sum response and each ring eccentricity), the other contains the average waveforms.
Script 3: 2D plots
This script extracts the peak characteristics of each hexagon as detected by the RETIport system. For each patient of 2 groups 4 2D hexagon plots are generated (N1 and P1 response density and implicit times) using the function "image. plot" from the package "fields". All plots are scaled equally to allow a better comparability. The averages of each group and the group differences are calculated and displayed in 2D hexagon plots (see the average P1 response density plot of both groups in the top row of Fig. 3 ).
Script 4: Interpolated 2D and 3D plots of averages and group differences
This script visualizes the averages of each group (Fig. 4 , top row) and the group differences (Fig. 4 , bottom left) in 2 and 3 dimensions. A raw 3D visualization of the hexagon matrix as used for script 3 would result in a "staircase" appearance of the plot. Therefore, interpolation was used to smooth the matrix beforehand. This pretends a higher spatial resolution than present in the original data. A 2D plot of the interpolated average differences is shown in the bottom right of Figure 4 . In the 3D plots, the values of the z axis (V/ deg 2 ) are grayscaled, with greater values being brighter than smaller values. This is enabled by the function "drape.plot" of the package "fields".
Script 5: t-Test plot with Bonferroni correction
A t-test comparison is done between both groups, for each peak characteristic and hexagon. The result is shown in 4 2D plots (N1 and P1 response density and implicit time; the comparison of P1 response density is shown in Fig. 3 , bottom right). Hexagons that show a significant difference between groups (p<0.05) are highlighted: dark gray indicates a significantly smaller value in group 1, light gray a significantly greater value in group 1. 
Script 6: Comparison of 2 groups based on manually compiled .csv files
This last script was written for users of other devices than a RETIport 21 system. Before its application, the user has to compile 2 .csv files (1 for each group) with the appropriate data manually and has to place them in the source directories. The required structure of these .csv files is given in the supplemental files available online at www.eur-j-ophthalmol. com. Each .csv file may contain the data of multiple patients but only of one peak characteristic and either right or left eye (e.g., P1 response density of the right eye). If both groups consist of more than one patient, the script calculates the group differences and exerts a t-test comparison with Bonferroni correction. A 2D difference plot is displayed and the p values for each hexagon are given Figure 3 . The color of the text in each hexagon indicates if the group average is greater, smaller, or equal in group 1 compared to group 2. Furthermore, hexagons that show significant differences between groups are asterisked and their text is highlighted.
If one or both groups consists of just a single patient, only the group differences are calculated and displayed in a 2D plot. Figure 1 shows the boxplots comparing 11 eyes with chloroquine maculopathy and 7 healthy eyes. Response densities are significantly reduced in the chloroquine patients as to ring 1 and 2 of P1 and ring 2 of N1. Implicit times are generally greater in the patients but no significant delay occurred. Figure 2 shows a comparison of the averaged trace arrays of both groups. As in Figure 1 , the amplitude reductions and implicit time delays in the chloroquine patients become apparent. For each group, the average is complemented by ± standard deviation (gray lines).
Results
A 2D visualization of the average P1 response densities of the eyes with chloroquine maculopathy (top left) and the 7 healthy eyes (top right) is shown in Figure 3 . For the sake of comparability, the z scales of the plots in the top row are scaled equally. Another plot indicates which hexagon shows a significant difference between both groups as calculated by the Bonferroni-corrected t-test (bottom left, response density of segment 30 being significantly smaller in group 1). The difference of the group averages as rendered by script 6 is displayed bottom right. As expected, the greatest differences between groups appear in the central and pericentral segments. In this plot, the p values are given for each hexagon and an indication if the group difference reaches a significant level. Figure 4 is an analogue to Figure 3 , showing the average P1 response densities of both groups (top row) and their difference (bottom left) but using an interpolated 3D visualization. Again, the scale of the z axis [V/deg 2 ] is the same in all 3 plots. An interpolated 2D difference plot is shown bottom right.
Discussion
Longitudinal comparisons of subsequent mfERG examinations on the same eye as well as comparisons between groups of patients can be cumbersome and time-consuming. The R scripts presented here enable the graphic presentation of more than one mfERG examination and the comparison of groups of subjects.
The functionality of the software is illustrated by comparing patients with chloroquine maculopathy and a healthy control group. First, the waveforms of a single patient or the averaged waveforms or boxplots of a patient group may be compared to another subject group (e.g., normative database). This allows a quick qualitative and quantitative comparison. The pattern of macular function can be identified in the 2D and 3D plots of each single examination, the group averages, and the group differences. A t-test plot shows which elements differ significantly between groups.
There is some overlap of information resulting from the different scripts. Therefore, it may not be necessary to apply all scripts on each patient/group. Clinicians and scientists may decide which type of analysis they find most helpful in their setting.
The results of automated threshold perimetry are typically depicted in direct comparison to the age-fitted control group instead of displaying the raw data of local sensitivity (16, 17) . Our 2D and 3D difference plots (Figs. 3 and 4) of the group averages are comparable to this presentation of visual field data and allow a better estimation of localized deficits in retinal function than the presentation of the patient data alone. In contrast to static perimetry, the quality of the mfERG recordings has to be estimated before calculating averages and differences. The visualization of each hexagon trace is not implemented in the script; therefore the trace arrays have to be reviewed beforehand on the recording device itself.
We are using these scripts to rule out toxic retinal damage in (hydroxy-)chloroquine patients or to differentiate maculopathy from macular dystrophy. What still slows down the analysis significantly is the fact that every single examination has to be exported manually from the recording device. Furthermore, as our recording device is not connected to the local area network or to the Internet and the R software is installed on another computer with higher performance, data transfer has to be done with a USB stick. Scripts 1 to 5 can only be applied on .csv files that were exported by a RETIport 21 system. Script 6 is platform-independent but requires the manual compilation of 2 .csv source files by the user. All scripts are declared open-source and the reader may feel free to adapt them to their specific needs and platforms.
Some issues should be addressed by a software update. Artificial distortion of the recordings could be measured automatically (18) . As mentioned above, in the current version the waveforms of each recording must be examined on the recording device before including the data into the analysis.
The current scripts always use the t-test to compare both groups. Prior testing for normal distribution should be integrated in the script.
An additional ring ratio analysis (R5-or R1-ratio) would especially be helpful in the diagnosis of toxic retinal damage (19, 20) .
The mfERG is an established electrophysiologic modality to assess macular function. The principles of stimulation and recording have not changed fundamentally over the years but modern devices add a variety of data illustration and analysis options. Our article exemplifies how older hardware and software can be upcycled to user-specific needs by a custommade software solution.
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